Full Text View
Tabular View
No Study Results Posted
Related Studies
Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery
This study is currently recruiting participants.
Study NCT00473564   Information provided by University of Alabama at Birmingham
First Received: May 14, 2007   Last Updated: February 12, 2009   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

May 14, 2007
February 12, 2009
February 2007
Assess exposure and access to oropharyngeal and hypopharyngeal head and neck lesions [ Time Frame: Post operatively and 3 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00473564 on ClinicalTrials.gov Archive Site
Assessment of patient safety and document surgical time and set-up [ Time Frame: Post operatively and 3 months ] [ Designated as safety issue: Yes ]
Same as current
 
Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery
Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery

To evaluate the use of the daVinci Robotic System for better visibility and access of head and neck lesions and decreased amount of surgery time.

This trial is a single institution non-randomized study to evaluate the efficacy and safety of the da Vinci® Robotic Surgical System. This study will evaluate the use of the daVinci Robotic System for better visibility and access of head and neck lesions and decreased amount of surgery time. This is a robotic system used by surgeons to perform surgery in a less invasive manner.

 
Interventional
Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
  • Oropharyngeal Lesions
  • Hypopharyngeal Lesions
  • Oral Cavity Lesions
Procedure: da Vinci® Robotic System
Active Comparator: Single Arm using da Vinci Robotic System
Boudreaux BA, Rosenthal EL, Magnuson JS, Newman JR, Desmond RA, Clemons L, Carroll WR. Robot-assisted surgery for upper aerodigestive tract neoplasms. Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):397-401.

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
40
February 2010
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Head and neck lesions requiring surgical resection, biopsy, or invasive treatment;
  • Lesion amendable to robotic assisted surgery treatment;
  • Age > 19 years;
  • Patient must sign informed consent.

Exclusion Criteria:

  • Psychological condition that renders the patient unable to understand the informed consent;
  • Poor mouth opening, with maximal opening less than 1.5 cm.
Both
20 Years and older
No
Contact: Lisa Clemons, RN (205) 934-9714 lkclemons@uabmc.edu
United States
 
 
NCT00473564
Eben Rosenthal, MD, University of Alabama at Birmingham
HNO 0601
University of Alabama at Birmingham
 
Principal Investigator: Eben Rosenthal, MD University of Alabama at Birmingham
University of Alabama at Birmingham
February 2009

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.